Expression and prognostic relevance of the death receptor CD95 (Fas/APO1) in renal cell carcinomas

CD95 (Fas/APO1) is one of the best known members of the death receptor family which can either mediate apoptosis or activate tumor-promoting pathways. Using a tissue microarray we investigated the association between the expression of CD95 and prognosis in 617 patients with renal cell carcinomas (RC...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Macher-Göppinger, Stephan (VerfasserIn) , Lorenzo Bermejo, Justo (VerfasserIn) , Wagener, Nina (VerfasserIn) , Hohenfellner, Markus (VerfasserIn) , Haferkamp, Axel (VerfasserIn) , Schirmacher, Peter (VerfasserIn) , Roth, Wilfried (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2011
In: Cancer letters
Year: 2011, Jahrgang: 301, Heft: 2, Pages: 203-211
ISSN:1872-7980
DOI:10.1016/j.canlet.2010.12.005
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.canlet.2010.12.005
Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S0304383510005550
Volltext
Verfasserangaben:Stephan Macher-Goeppinger, Justo Lorenzo Bermejo, Nina Wagener, Markus Hohenfellner, Axel Haferkamp, Peter Schirmacher, Wilfried Roth

MARC

LEADER 00000caa a2200000 c 4500
001 1823198341
003 DE-627
005 20230710101704.0
007 cr uuu---uuuuu
008 221122s2011 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.canlet.2010.12.005  |2 doi 
035 |a (DE-627)1823198341 
035 |a (DE-599)KXP1823198341 
035 |a (OCoLC)1389748530 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Macher-Göppinger, Stephan  |e VerfasserIn  |0 (DE-588)1022394061  |0 (DE-627)716963299  |0 (DE-576)365275034  |4 aut 
245 1 0 |a Expression and prognostic relevance of the death receptor CD95 (Fas/APO1) in renal cell carcinomas  |c Stephan Macher-Goeppinger, Justo Lorenzo Bermejo, Nina Wagener, Markus Hohenfellner, Axel Haferkamp, Peter Schirmacher, Wilfried Roth 
264 1 |c 2011 
300 |a 9 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 22.11.2022 
520 |a CD95 (Fas/APO1) is one of the best known members of the death receptor family which can either mediate apoptosis or activate tumor-promoting pathways. Using a tissue microarray we investigated the association between the expression of CD95 and prognosis in 617 patients with renal cell carcinomas (RCCs). CD95 was expressed in the vast majority of RCCs. High CD95 expression was associated with lymph node metastasis and correlated negatively with disease-specific survival. Multivariate Cox regression analysis confirmed CD95 expression as an independent prognostic factor. In conclusion, high CD95 expression is a negative independent prognostic factor in RCCs which could be used to identify high-risk patients with a poor clinical prognosis. 
650 4 |a Apoptosis 
650 4 |a CD95 (Fas/APO1) 
650 4 |a Prognostic factors 
650 4 |a Renal cell cancer 
700 1 |a Lorenzo Bermejo, Justo  |d 1972-  |e VerfasserIn  |0 (DE-588)124754619  |0 (DE-627)706705572  |0 (DE-576)294483632  |4 aut 
700 1 |a Wagener, Nina  |d 1977-  |e VerfasserIn  |0 (DE-588)13005643X  |0 (DE-627)488796024  |0 (DE-576)189332689  |4 aut 
700 1 |a Hohenfellner, Markus  |d 1958-  |e VerfasserIn  |0 (DE-588)133862518  |0 (DE-627)557857988  |0 (DE-576)300155263  |4 aut 
700 1 |a Haferkamp, Axel  |e VerfasserIn  |4 aut 
700 1 |a Schirmacher, Peter  |d 1961-  |e VerfasserIn  |0 (DE-588)1020440112  |0 (DE-627)691221197  |0 (DE-576)360427448  |4 aut 
700 1 |a Roth, Wilfried  |d 1970-  |e VerfasserIn  |0 (DE-588)120891557  |0 (DE-627)080951279  |0 (DE-576)292433484  |4 aut 
773 0 8 |i Enthalten in  |t Cancer letters  |d Amsterdam [u.a.] : Elsevier Science, 1975  |g 301(2011), 2, Seite 203-211  |h Online-Ressource  |w (DE-627)320434796  |w (DE-600)2004212-7  |w (DE-576)261677926  |x 1872-7980  |7 nnas  |a Expression and prognostic relevance of the death receptor CD95 (Fas/APO1) in renal cell carcinomas 
773 1 8 |g volume:301  |g year:2011  |g number:2  |g pages:203-211  |g extent:9  |a Expression and prognostic relevance of the death receptor CD95 (Fas/APO1) in renal cell carcinomas 
776 0 8 |i Erscheint auch als  |n Druck-Ausgabe  |t Expression and prognostic relevance of the death receptor CD95 (Fas/APO1) in renal cell carcinomas  |d 2011  |w (DE-627)1632936461  |w (DE-576)366178466 
856 4 0 |u https://doi.org/10.1016/j.canlet.2010.12.005  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.sciencedirect.com/science/article/pii/S0304383510005550  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20221122 
993 |a Article 
994 |a 2011 
998 |g 120891557  |a Roth, Wilfried  |m 120891557:Roth, Wilfried  |d 910000  |d 912000  |e 910000PR120891557  |e 912000PR120891557  |k 0/910000/  |k 1/910000/912000/  |p 7  |y j 
998 |g 1020440112  |a Schirmacher, Peter  |m 1020440112:Schirmacher, Peter  |d 910000  |d 912000  |e 910000PS1020440112  |e 912000PS1020440112  |k 0/910000/  |k 1/910000/912000/  |p 6 
998 |g 133862518  |a Hohenfellner, Markus  |m 133862518:Hohenfellner, Markus  |d 910000  |d 910200  |e 910000PH133862518  |e 910200PH133862518  |k 0/910000/  |k 1/910000/910200/  |p 4 
998 |g 13005643X  |a Wagener, Nina  |m 13005643X:Wagener, Nina  |d 910000  |d 910200  |e 910000PW13005643X  |e 910200PW13005643X  |k 0/910000/  |k 1/910000/910200/  |p 3 
998 |g 124754619  |a Lorenzo Bermejo, Justo  |m 124754619:Lorenzo Bermejo, Justo  |d 910000  |d 999701  |d 50000  |e 910000PL124754619  |e 999701PL124754619  |e 50000PL124754619  |k 0/910000/  |k 1/910000/999701/  |k 0/50000/  |p 2 
998 |g 1022394061  |a Macher-Göppinger, Stephan  |m 1022394061:Macher-Göppinger, Stephan  |d 910000  |d 912000  |e 910000PM1022394061  |e 912000PM1022394061  |k 0/910000/  |k 1/910000/912000/  |p 1  |x j 
999 |a KXP-PPN1823198341  |e 4218293236 
BIB |a Y 
SER |a journal 
JSO |a {"type":{"bibl":"article-journal","media":"Online-Ressource"},"id":{"doi":["10.1016/j.canlet.2010.12.005"],"eki":["1823198341"]},"physDesc":[{"extent":"9 S."}],"relHost":[{"language":["eng"],"disp":"Expression and prognostic relevance of the death receptor CD95 (Fas/APO1) in renal cell carcinomasCancer letters","recId":"320434796","pubHistory":["1.1975 -"],"type":{"media":"Online-Ressource","bibl":"periodical"},"title":[{"title":"Cancer letters","subtitle":"an international journal providing a forum for original and pertinent contributions in cancer research","title_sort":"Cancer letters"}],"origin":[{"dateIssuedKey":"1975","publisherPlace":"Amsterdam [u.a.]","publisher":"Elsevier Science","dateIssuedDisp":"1975-"}],"note":["Gesehen am 22.01.2020"],"id":{"issn":["1872-7980"],"zdb":["2004212-7"],"eki":["320434796"]},"part":{"year":"2011","pages":"203-211","text":"301(2011), 2, Seite 203-211","volume":"301","extent":"9","issue":"2"},"physDesc":[{"extent":"Online-Ressource"}]}],"note":["Gesehen am 22.11.2022"],"recId":"1823198341","name":{"displayForm":["Stephan Macher-Goeppinger, Justo Lorenzo Bermejo, Nina Wagener, Markus Hohenfellner, Axel Haferkamp, Peter Schirmacher, Wilfried Roth"]},"origin":[{"dateIssuedKey":"2011","dateIssuedDisp":"2011"}],"person":[{"role":"aut","family":"Macher-Göppinger","given":"Stephan","display":"Macher-Göppinger, Stephan"},{"role":"aut","family":"Lorenzo Bermejo","given":"Justo","display":"Lorenzo Bermejo, Justo"},{"given":"Nina","display":"Wagener, Nina","family":"Wagener","role":"aut"},{"role":"aut","family":"Hohenfellner","display":"Hohenfellner, Markus","given":"Markus"},{"given":"Axel","display":"Haferkamp, Axel","family":"Haferkamp","role":"aut"},{"family":"Schirmacher","given":"Peter","display":"Schirmacher, Peter","role":"aut"},{"family":"Roth","display":"Roth, Wilfried","given":"Wilfried","role":"aut"}],"language":["eng"],"title":[{"title":"Expression and prognostic relevance of the death receptor CD95 (Fas/APO1) in renal cell carcinomas","title_sort":"Expression and prognostic relevance of the death receptor CD95 (Fas/APO1) in renal cell carcinomas"}]} 
SRT |a MACHERGOEPEXPRESSION2011